Health
China’s CAS COVID-19 vaccine induces immune response in mid-stage tests – Reuters
A coronavirus vaccine candidate developed by the Chinese Academy of Sciences (CAS) was found to be safe and triggered immune responses in early and mid-stage trials,…
By Reuters Staff
BEIJING (Reuters) – A coronavirus vaccine candidate developed by the Chinese Academy of Sciences (CAS) was found to be safe and triggered immune responses in early and mid-stage trials, researchers said on Tuesday.
FILE PHOTO: The word “COVID-19” is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
A late-stage trial of the ZF2001 vaccine, which CAS is developing with a unit of Chongqing Zhifei Biological…
-
Noosa News21 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News14 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General14 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News23 hours agoCampers evacuated as fire crews battle blaze